FDA Approves First Adjuvant Therapy for Most Common Type of Lung Cancer

Today, the FDA approved the first adjuvant treatment for patients with non-small cell lung cancer whose tumors have a specific type of genetic mutation.

Source: FDA Center for Drug Evaluation and Research - What's New - December 18, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news